186 related articles for article (PubMed ID: 34205940)
1. DIC-Like Syndrome Following Administration of ChAdOx1 nCov-19 Vaccination.
Casucci G; Acanfora D
Viruses; 2021 Jun; 13(6):. PubMed ID: 34205940
[TBL] [Abstract][Full Text] [Related]
2. Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea.
Bae S; Lee YW; Lim SY; Lee JH; Lim JS; Lee S; Park S; Kim SK; Lim YJ; Kim EO; Jung J; Kwon HS; Kim TB; Kim SH
J Korean Med Sci; 2021 May; 36(17):e115. PubMed ID: 33942579
[TBL] [Abstract][Full Text] [Related]
3. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).
Román GC; Gracia F; Torres A; Palacios A; Gracia K; Harris D
Front Immunol; 2021; 12():653786. PubMed ID: 33981305
[TBL] [Abstract][Full Text] [Related]
4. Sustained COVID-19 vaccine willingness after safety concerns over the Oxford-AstraZeneca vaccine.
Sønderskov KM; Dinesen PT; Østergaard SD
Dan Med J; 2021 Mar; 68(5):. PubMed ID: 33870886
[TBL] [Abstract][Full Text] [Related]
5. A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
Kim G; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH
J Korean Med Sci; 2021 Nov; 36(43):e306. PubMed ID: 34751013
[TBL] [Abstract][Full Text] [Related]
6. A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine.
Nasuelli NA; De Marchi F; Cecchin M; De Paoli I; Onorato S; Pettinaroli R; Savoini G; Godi L
Neurol Sci; 2021 Nov; 42(11):4747-4749. PubMed ID: 34272622
[TBL] [Abstract][Full Text] [Related]
7. Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19).
Paulsen FO; Schaefers C; Langer F; Frenzel C; Wenzel U; Hengel FE; Bokemeyer C; Seidel C
Blood; 2021 Sep; 138(11):996-999. PubMed ID: 34297792
[No Abstract] [Full Text] [Related]
8. Coincidental Onset of Ocular Myasthenia Gravis Following ChAdOx1 n-CoV-19 Vaccine against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Galassi G; Rispoli V; Iori E; Ariatti A; Marchioni A
Isr Med Assoc J; 2022 Jan; 24(1):9-10. PubMed ID: 35077038
[TBL] [Abstract][Full Text] [Related]
9. Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen.
Soltani Hekmat A; Javanmardi K
Biomed Res Int; 2021; 2021():7702863. PubMed ID: 34734086
[TBL] [Abstract][Full Text] [Related]
10. Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System.
Jeon M; Kim J; Oh CE; Lee JY
J Korean Med Sci; 2021 May; 36(17):e114. PubMed ID: 33942578
[TBL] [Abstract][Full Text] [Related]
11. A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2.
Tølbøll Sørensen AL; Rolland M; Hartmann J; Harboe ZB; Roed C; Jensen TØ; Kolte L; El Fassi D; Hillingsø J; Radziwon-Balicka A; Soyka RS; Hansen K; Kirkby N; Goetze JP; Gybel-Brask M; Leinøe EB; Hvas AM; Kampmann P; Stensballe J
Blood Adv; 2021 Jun; 5(12):2569-2574. PubMed ID: 34137813
[TBL] [Abstract][Full Text] [Related]
12. Early Safety Monitoring of COVID-19 Vaccines in Healthcare Workers.
Song JY; Cheong HJ; Kim SR; Lee SE; Kim SH; Noh JY; Yoon YK; Choi WS; Park DW; Sohn JW; Kim WJ; Kim MJ
J Korean Med Sci; 2021 Apr; 36(15):e110. PubMed ID: 33876589
[TBL] [Abstract][Full Text] [Related]
13. Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia.
De Michele M; Iacobucci M; Chistolini A; Nicolini E; Pulcinelli F; Cerbelli B; Merenda E; Schiavo OG; Sbardella E; Berto I; Petraglia L; Caracciolo N; Chiara M; Truglia S; Toni D
Nat Commun; 2021 Aug; 12(1):4663. PubMed ID: 34341358
[TBL] [Abstract][Full Text] [Related]
14. ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets.
Marsh GA; McAuley AJ; Au GG; Riddell S; Layton D; Singanallur NB; Layton R; Payne J; Durr PA; Bender H; Barr JA; Bingham J; Boyd V; Brown S; Bruce MP; Burkett K; Eastwood T; Edwards S; Gough T; Halpin K; Harper J; Holmes C; Horman WSJ; van Vuren PJ; Lowther S; Maynard K; McAuley KD; Neave MJ; Poole T; Rootes C; Rowe B; Soldani E; Stevens V; Stewart CR; Suen WW; Tachedjian M; Todd S; Trinidad L; Walter D; Watson N; Drew TW; Gilbert SC; Lambe T; Vasan SS
NPJ Vaccines; 2021 May; 6(1):67. PubMed ID: 33972565
[TBL] [Abstract][Full Text] [Related]
15. Bullous Sweet syndrome following SARS-CoV-2 Oxford AstraZeneca vaccine.
Žagar T; Hlača N; Brajac I; Prpić-Massari L; Peternel S; Kaštelan M
Br J Dermatol; 2022 Mar; 186(3):e110. PubMed ID: 34817862
[No Abstract] [Full Text] [Related]
16. Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female.
Majid I; Mearaj S
Dermatol Ther; 2021 Nov; 34(6):e15146. PubMed ID: 34590397
[TBL] [Abstract][Full Text] [Related]
17. A Quantitative Benefit-Risk Analysis of ChAdOx1 nCoV-19 Vaccine among People under 60 in Italy.
Palladino R; Ceriotti D; De Ambrosi D; De Vito M; Farsoni M; Seminara G; Barone-Adesi F
Vaccines (Basel); 2021 Jun; 9(6):. PubMed ID: 34201330
[TBL] [Abstract][Full Text] [Related]
18. Interim statement of the COVID-19 subcommittee of the WHO Global Advisory Committee on vaccine safety on AstraZeneca COVID-19 vaccine.
Saudi Med J; 2021 May; 42(5):581-582. PubMed ID: 33896793
[No Abstract] [Full Text] [Related]
19. Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: a case report.
Tan WY; Yusof Khan AHK; Mohd Yaakob MN; Abdul Rashid AM; Loh WC; Baharin J; Ibrahim A; Ismail MR; Inche Mat LN; Wan Sulaiman WA; Basri H; Hoo FK
BMC Neurol; 2021 Oct; 21(1):395. PubMed ID: 34641797
[TBL] [Abstract][Full Text] [Related]
20. Takotsubo (stress) cardiomyopathy after ChAdOx1 nCoV-19 vaccination.
Crane P; Wong C; Mehta N; Barlis P
BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34625447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
